CYTOKINETICS INC. 2023-2024 Proxy Voting Records

Description as filed by funds: To elect two Class II Directors: Robert I. Blum

CYTOKINETICS INC.’s own tally for this item (“Elect Director: Robert I. Blum”): 87,317,169 for, 2,214,926 withheld, per its Form 8-K filed May 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 104 asset managers below reported 45,527,244 for, 155,749 withheld.

Showing the 25 largest of 104 asset managers. See all 104 in the interactive database.

The 67 asset managers below reported 32,736,452 for, 7,059,645 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.

Description as filed by funds: ELECTION OF CLASS II DIRECTOR: ROBERT A. HARRINGTON, M.D.

CYTOKINETICS INC.’s own tally for this item (“Elect Director: Robert A. Harrington, M.D.”): 78,347,186 for, 11,184,909 withheld, per its Form 8-K filed May 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 45 managers: 5,543,503 for, 282,768 withheld. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 2 managers: 60,625 for.

Description as filed by funds: To approve the amendment and restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of authorized shares reserved for issuance under such plan by 300,000 shares of common stock.

CYTOKINETICS INC.’s own tally for this item (“2. Approval of the Amendment and Restatement of the Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of shares authorized for issuance under such plan by 300,000 shares of common stock”): 88,586,473 for, 481,098 against — passed, per its Form 8-K filed May 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved the Amendment and Restatement of the Company's Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of shares authorized for issuance under such plan by 300,000 shares of common stock.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 107 asset managers below reported 45,590,225 for, 121,254 against.

Showing the 25 largest of 107 asset managers. See all 107 in the interactive database.

Description as filed by funds: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.

CYTOKINETICS INC.’s own tally for this item (“4. Advisory Vote on Executive Compensation”): 85,814,395 for, 2,927,007 against — passed, per its Form 8-K filed May 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4: Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the named executive officers, as disclosed in the 2024 Proxy Statement.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 102 managers: 44,839,993 for, 745,054 against, 41,994 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 299 managers: 58,120,322 for, 2,439,401 against, 34,491 withheld, 407,286 abstained, 270 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.

CYTOKINETICS INC.’s own tally for this item (“3. Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024”): 95,957,265 for, 97,750 against — passed, per its Form 8-K filed May 17, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024 The stockholders ratified the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent…”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 104 asset managers below reported 45,640,683 for, 316 against, 41,994 abstained.

Showing the 25 largest of 104 asset managers. See all 104 in the interactive database.